Skip to main content
. 2022 Nov 29;2022(11):CD012053. doi: 10.1002/14651858.CD012053.pub2

JPRN‐UMIN000004351.

Methods Parallel Randomised
Participants Adults with colon cancer
Interventions FOLFOX4
FOLFOX6
FOLFOX/Krestin
Outcomes Frequency of neutropenia
Other adverse events
Medication adherence
QOL
Notes OPEN PUBLIC RECRUITING (as of 19/10/2012)